Phase 3 Diabetic Macular Edema (DME) Study
Now Open in Cincinnati, OH
● Now Enrolling
When blood sugar is too high, the blood vessels in the retina of the eye can become blocked. If these blocked blood vessels become too large, they can leak fluid into the macula of the eye, causing edema. Due to the high amounts of sugar in the blood stream, diabetics (both Type 1 and 2) are at risk of developing Diabetic Macular Edema (DME). This serious eye condition can cause vision problems and even blindness.
People aged 18 or older with may be eligible to join this research study of an investigational treatment for DME. Eligible participants will receive compensation for study-related time, as well as study-related exams at no cost.
Eligible participants…
- Must be age 18 or older
- Must have been diagnosed with Diabetes (Type 1 or 2) and Diabetic Macular Edema
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.
Submit your information
Study Location
Meridian Clinical Research
2055 Reading Rd., Suite 330
Cincinnati, OH 45202
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2021 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy